David C. Hodgson - 05 Jun 2026 Form 4 Insider Report for Royalty Pharma plc (RPRX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
08 Jun 2026, 16:26:14 UTC
Prior SEC filing
01 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Sean Weisberg, as Attorney-in-Fact for David C. Hodgson

Key filing fact

David C. Hodgson filed Form 4 for Royalty Pharma plc (RPRX) on 08 Jun 2026.

Key facts

  • This page summarizes David C. Hodgson's Form 4 filing for Royalty Pharma plc (RPRX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 08 Jun 2026, 16:26.

Change

  • Previous filing in this sequence was filed on 01 Jun 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001193346 Primary reporting owner

HODGSON DAVID C

Relationship
Director
Address
C/O ROYALTY PHARMA PLC, 110 E. 59TH STREET, NEW YORK
Signature
/s/ Sean Weisberg, as Attorney-in-Fact for David C. Hodgson
Signature date
08 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RPRX transaction

Class A Ordinary Shares

Award

Transaction value
Shares
+4,545
Change %
+14%
Price
$0.000000*
Shares after
37,873
Date
05 Jun 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Reflects an award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the "Plan") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder. The restricted stock units granted to the Reporting Person are held by him solely for the benefit of General Atlantic Service Company, L.P. The Reporting Person disclaims beneficial ownership of the restricted stock units in the underlying shares.

SEC remarks

In addition to the Class A Ordinary Shares disclosed above, the Reporting Person holds limited partnership interests in RPI US Partners 2019, LP exchangeable into 79,476 Class A Ordinary Shares.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .